Sightgene, Inc
Sightgene, Inc., located in Monrovia, California, is a research organization focused on advancing the understanding and treatment of primary open-angle glaucoma (POAG), a leading cause of irreversible blindness worldwide. The company aims to develop more effective clinical therapies by investigating the underlying mechanisms of glaucoma pathogenesis and exploring innovative treatment strategies.
Through its research, Sightgene, Inc. utilizes unique mouse models to study the genetic factors associated with POAG, particularly the role of fibrillin-1 and transforming growth factor 2 (TGF2) in disease progression. By characterizing these mechanisms, the organization seeks to improve patient outcomes and preserve vision for those affected by this chronic condition.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.